Patrick Julier
Impact in
-
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Screening and Detection
-
- Inflammatory mediators and NSAID effects
Papers in
- Oncology 5
- Colorectal Cancer Treatments and Studies 3
- PARP inhibition in cancer therapy 1
- Pancreatic and Hepatic Oncology Research 1
-
- Inflammatory mediators and NSAID effects 3
- Co-authors
- Janet Dunn (3 shared papers)Rachel Midgley (5 shared papers)M. J. S. Langman (2 shared papers)Christopher C. McConkey (2 shared papers)Elaine Johnstone (3 shared papers)Rachel Kerr (3 shared papers)Andrew Stanley (1 shared paper)David J. Kerr (1 shared paper)
- Journals
- Annals of Oncology (4 papers)Journal of Clinical Oncology (3 papers)Trials (1 paper)New England Journal of Medicine (1 paper)The Lancet Oncology (1 paper)
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
Patrick Julier
9 papers receiving 308 citations
Peers
Comparison fields: 5 of 53
- Oncology 134
- Pharmacology 80
- Cancer Research 54
- Pathology and Forensic Medicine 43
- Pulmonary and Respiratory Medicine 51
Countries citing papers authored by Patrick Julier
This map shows the geographic impact of Patrick Julier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Julier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Julier more than expected).
Fields of papers citing papers by Patrick Julier
This network shows the impact of papers produced by Patrick Julier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Julier. The network helps show where Patrick Julier may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Julier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 104 | |
| 2 | 2016 | 100 | |
| 3 | 2010 | 70 | |
| 4 | VICTOR: A PHASE III PLACEBO-CONTROLLED TRIAL OF ROFECOXIB IN COLORECTAL CANCER PATIENTS FOLLOWING SURGICAL RESECTION | 2008 | 14 |
| 5 | 2012 | 13 | |
| 6 | 2014 | 7 | |
| 7 | 2013 | 4 | |
| 8 | 2022 | 2 | |
| 9 | 2012 | 2 | |
| 10 | 2013 | 1 | |
| 11 | 2024 | 0 |
About Patrick Julier
Patrick Julier is a scholar working on Oncology, Pharmacology, Surgery, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 11 papers that have together received 317 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Gastric Cancer Management and Outcomes (2 papers), Esophageal Cancer Research and Treatment (2 papers), PARP inhibition in cancer therapy (1 paper), DNA Repair Mechanisms (1 paper), Eicosanoids and Hypertension Pharmacology (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Oncology (134 citations), Pharmacology (80 citations), Cancer Research (54 citations), Pathology and Forensic Medicine (43 citations) and Pulmonary and Respiratory Medicine (51 citations). Patrick Julier has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Janet Dunn, Rachel Midgley, M. J. S. Langman, Christopher C. McConkey, Elaine Johnstone, Rachel Kerr, Andrew Stanley, David J. Kerr, Andrew Weaver and Ian Tomlinson. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Trials, New England Journal of Medicine and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.